[The influence of betaserk and cinarizine on vestibular function, highest nervous activity and brain circulation in chronic cerebral ischemia: a model study].
T R
TR
Grishina
O A
OA
Gromova
A V
AV
Sadin
O A
OA
Nazarenko
N Iu
NIu
Zhidomorov
M P
MP
Borzunov
A A
AA
Vatsuro
A A
AA
Nikonov
D000276:Adjuvants, Immunologic / Q000494:pharmacology* / Q000627:therapeutic use*; D000818:Animals; D001921:Brain / Q000098:blood supply* / Q000187:drug effects*; D002545:Brain Ischemia / Q000188:drug therapy* / Q000503:physiopathology*; D002121:Calcium Channel Blockers / Q000494:pharmacology* / Q000627:therapeutic use*; D002908:Chronic Disease; D002936:Cinnarizine / Q000494:pharmacology* / Q000627:therapeutic use*; D004195:Disease Models, Animal; D006439:Hemodynamics / Q000187:drug effects; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000494:pharmacology* / Q000627:therapeutic use*; D011434:Proprioception / Q000187:drug effects*; D051381:Rats; D014722:Vestibule, Labyrinth / Q000187:drug effects*
D000276:Adjuvants, Immunologic; D002121:Calcium Channel Blockers; D000068576:Interferon beta-1b; D002936:Cinnarizine; D016899:Interferon-beta